isovitexin has been researched along with Colorectal Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Chen, G; Li, J; Lin, Q; Liu, N; Shang, L; Wang, S; Yang, S; Zhang, M; Zhou, F; Zhou, M | 1 |
1 other study(ies) available for isovitexin and Colorectal Cancer
| Article | Year |
|---|---|
Herba Patriniae and its component Isovitexin show anti-colorectal cancer effects by inducing apoptosis and cell-cycle arrest via p53 activation.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Colorectal Neoplasms; Drugs, Chinese Herbal; Genes, cdc; Humans; Tumor Suppressor Protein p53 | 2023 |